Lawyer Urges China To Launch Own Probe Of Pfizer Bribery Allegations
This article was originally published in PharmAsia News
Executive Summary
A Beijing lawyer has urged Chinese authorities to conduct their own investigation of Pfizer's alleged bribes of regulators and medical workers in China.
You may also be interested in...
Dainippon, SanBio Call Time On Stroke Cell Therapy Alliance
Japanese companies agree to discontinue regenerative cell therapy pact after high-profile Phase II failure, but SanBio will move ahead with development and Dainippon will hold onto ex-partner stake for now.
Strides Targets $200-400m From Generic Injectables In Mid-Term
Strides has set a sales target of $200-400m for Stelis’s generic injectables business in two to four years as part of its plan to reach $800m in total revenues in four years. Meanwhile, Stelis’s Rh-teriparatide for osteoporosis and sodium hyaluronate for osteoarthritis await Phase III incremental studies in the US.
Abbott Readying Vildagliptin ER In India Amid Price Competition
Need a specific report? 1000+ reports available
Buy Reports